| Literature DB >> 28879055 |
Pingling Zeng1, Camilla Bengtsson1, Lars Klareskog2, Lars Alfredsson1,3.
Abstract
OBJECTIVES: To investigate (1) whether working in cold environment (WCE) is associated with an increased risk of developing rheumatoid arthritis (RA) (overall), anticitrullinated protein antibody (ACPA)-positive RA and ACPA-negative RA and (2) whether WCE interacts with occupational physical workload in conferring RA risk.Entities:
Keywords: anti-citrullinated protein antibody (ACPA); cold work environment; rheumatoid arthritis
Year: 2017 PMID: 28879055 PMCID: PMC5574417 DOI: 10.1136/rmdopen-2017-000488
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
ORs of developing RA (overall), ACPA-positive RA and ACPA-negative RA for subjects worked in the cold, in cold outdoor and cold indoor environment
| RA (overall) | ACPA-positive RA | ACPA-negative RA | ||||
| Exposure | Cases/controls | OR | Cases/controls | OR | Cases/controls | OR |
| Unexposed | 2783/4815 | 1.0 (ref.) | 1811/4815 | 1.0 (ref.) | 972/4815 | 1.0 (ref.) |
| Cold* | ||||||
| Ever | 853/1023 | 1.5 (1.4 to 1.7) | 574/1023 | 1.6 (1.4 to 1.8) | 279/1023 | 1.4 (1.2 to 1.6) |
| Current | 354/392 | 1.6 (1.4 to 1.9) | 236/392 | 1.7 (1.4 to 2.0) | 118/392 | 1.5 (1.2 to 1.9) |
| Past | 499/631 | 1.4 (1.3 to 1.7) | 338/631 | 1.5 (1.3 to 1.8) | 161/631 | 1.3 (1.0 to 1.5) |
| Cold outdoor† | ||||||
| Ever | 658/805 | 1.5 (1.3 to 1.7) | 435/805 | 1.5 (1.3 to 1.7) | 223/805 | 1.4 (1.1 to 1.6) |
| Current | 289/339 | 1.5 (1.3 to 1.8) | 188/339 | 1.5 (1.2 to 1.8) | 101/339 | 1.5 (1.2 to 1.9) |
| Past | 369/466 | 1.4 (1.2 to 1.7) | 247/466 | 1.5 (1.3 to 1.8) | 122/466 | 1.3 (1.0 to 1.6) |
| Cold indoor† | ||||||
| Ever | 175/177 | 1.7 (1.4 to 2.1) | 125/177 | 1.9 (1.5 to 2.4) | 50/177 | 1.4 (1.0 to 1.9) |
| Current | 60/47 | 2.3 (1.6 to 3.4) | 46/47 | 2.8 (1.8 to 4.2) | 14/47 | 1.5 (0.8 to 2.8) |
| Past | 115/130 | 1.5 (1.2 to 2.0) | 79/130 | 1.6 (1.2 to 2.1) | 36/130 | 1.4 (0.9 to 2.0) |
*Missing information on 23 (0.6%) cases and 87 (1.5%) controls.
Missing information on 43 (1.2%) cases and 128 (2.2%) controls.
ACPA, anticitrullinated protein antibody; RA, rheumatoid arthritis.
OR adjusted for age (10 strata) sex, residential area and recruitment time period (1996–2006 and 2006–2014).
ORs of developing RA (overall) for subjects worked in cold indoor by duration, intensity, cumulative dose and cessation
|
|
|
|
|
| Unexposed | 2783/4815 | 1.0 (ref.) | 1.0 (ref.) |
| <10 | 85/98 | 1.5 (1.1 to 2.0) | 1.3 (0.9 to 1.8) |
| 10–19 | 45/46 | 1.7 (1.1 to 2.5) | 1.5 (0.9 to 2.4) |
| ≥20 | 43/31 | 2.5 (1.5 to 4.0) | 2.0 (1.2 to 3.4) |
| p for trend | <0.001 | <0.001 | |
|
| |||
| Unexposed | 2783/4815 | 1.0 (ref.) | 1.0 (ref.) |
| <10 | 52/74 | 1.2 (0.9 to 1.8) | 1.0 (0.7 to 1.5) |
| 10–19 | 27/25 | 1.9 (1.1 to 3.3) | 1.9 (1.1 to 3.6) |
| ≥20 | 77/64 | 2.1 (1.5 to 2.9) | 1.8 (1.2 to 2.6) |
| p for trend | <0.001 | <0.001 | |
|
| |||
| Unexposed | 2783/4815 | 1.0 (ref.) | 1.0 (ref.) |
| <5 | 100/127 | 1.4 (1.0 to 1.8) | 1.2 (0.9 to 1.7) |
| 5–9 | 27/16 | 2.8 (1.5 to 5.3) | 1.9 (1.0 to 3.9) |
| ≥10 | 29/18 | 2.8 (1.5 to 5.1) | 2.4 (1.3 to 4.6) |
| p for trend | <0.001 | <0.001 | |
|
| |||
| Unexposed | 2783/4815 | 1.0 (ref.) | 1.0 (ref.) |
| <10 | 53/50 | 1.8 (1.2 to 2.6) | 1.6 (1.1 to 2.5) |
| 10–19 | 33/40 | 1.3 (0.8 to 2.2) | 1.2 (0.7 to 2.0) |
| ≥20 | 27/38 | 1.3 (0.8 to 2.1) | 1.2 (0.7 to 2.0) |
| p for trend | 0.001 | 0.023 | |
*OR adjusted for age (10 strata) sex, residential area and recruitment time period (1996–2006 and 2006–2014).
†OR adjusted for age (10 strata) sex, residential area, recruitment time period (1996–2006 and 2006–2014), cigarette smoking, body mass index, alcohol consumption, university education and silica exposure.
Cumulative dose is the product of duration and intensity.
One work-year is equivalent to 2080 hours.
ORs of developing RA (overall) among subjects exposed to prolonged repetitive physical workload and cold work environment 5 years before baseline
| Cold work environment | |||||||
| Physical workload* | Unexposed | Exposed | |||||
| Cases/controls | OR | Cases/controls | OR | AP (95% CI) | p Value | ||
| Bending/turning | Unexposed | 804/1799 | 1.0 (ref.) | 84/88 | 2.1 (1.5 to 2.9) | −0.2 (−0.6 to 0.1) | 0.190 |
| Exposed | 1376/1925 | 1.5 (1.3 to 1.7) | 313/339 | 2.1 (1.7 to 2.5) | |||
| Repetitive hand/finger movements | Unexposed | 611/1223 | 1.0 (ref.) | 131/193 | 1.4 (1.1 to 1.8) | 0.3 (0.1 to 0.5) | <0.001 |
| Exposed | 1566/2499 | 1.3 (1.2 to 1.5) | 266/234 | 2.6 (2.1 to 3.2) | |||
| Carry more than 10 kg | Unexposed | 1152/2265 | 1.0 (ref.) | 49/60 | 1.7 (1.1 to 2.5) | 0.0 (−0.4 to 0.3) | 0.871 |
| Exposed | 1026/1462 | 1.4 (1.2 to 1.5) | 348/367 | 2.0 (1.7 to 2.4) | |||
| Hands below knee level | Unexposed | 1846/3316 | 1.0 (ref.) | 172/201 | 1.6 (1.3 to 2.0) | −0.1 (−0.3 to 0.2) | 0.687 |
| Exposed | 331/406 | 1.4 (1.2 to 1.7) | 223/224 | 1.9 (1.6 to 2.4) | |||
| Vibration | Unexposed | 1979/3407 | 1.0 (ref.) | 175/211 | 1.5 (1.2 to 1.8) | 0.2 (−0.1 to 0.4) | 0.127 |
| Exposed | 202/316 | 1.2 (1.0 to 1.5) | 221/212 | 2.0 (1.6 to 2.5) | |||
| Hands above shoulder level | Unexposed | 1682/3146 | 1.0 (ref.) | 163/216 | 1.4 (1.0 to 1.8) | 0.1 (−0.1 to 0.4) | 0.226 |
| Exposed | 495/578 | 1.5 (1.3 to 1.8) | 234/210 | 2.3 (1.9 to 2.8) | |||
Baseline is the year when the participants were recruited (ie, at the time when the patients were diagnosed).
*Missing information on 126 (3.4%) cases and 297 (5.0%) controls.
OR adjusted for age (10 strata), sex, residential area and recruitment time period (1996–2006 and 2006–2014).
AP, attributable proportion due to interaction; RA, rheumatoid arthritis.